✦ LIBER ✦

Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension

✍ Scribed by Gregory D. Lewis; Marc J. Semigran

Publisher: Current Science Inc.
Year: 2004
Tongue: English
Weight: 332 KB
Volume: 1
Category: Article
ISSN: 1546-9530
DOI: 10.1007/s11897-004-0007-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phosphodiesterase type 5 inhibitors in p

Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension

✍ David Montani; Marie-Camille Chaumais; Laurent Savale; Delphine Natali; Laura C. 📂 Article 📅 2009 🏛 Springer Healthcare Communications 🌐 English ⚖ 216 KB

The emerging role for type 5 phosphodies

The emerging role for type 5 phosphodiesterase inhibition in heart failure

✍ Gregory D. Lewis; Marc J. Semigran 📂 Article 📅 2006 🏛 Current Science Inc. 🌐 English ⚖ 498 KB

Pulmonary Hypertension in Advanced Heart

Pulmonary Hypertension in Advanced Heart Failure

✍ Stefano Ghio 📂 Article 📅 2005 🏛 Urban and Vogel 🌐 German ⚖ 383 KB

Pulmonary Hypertension, Sleep-Disordered

Pulmonary Hypertension, Sleep-Disordered Breathing, and Beta Blockers in Heart Failure Patients

✍ Robert P. Blankfield 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 73 KB

Type V phosphodiesterase inhibition modu

Type V phosphodiesterase inhibition modulates endogenous immunoreactivities of endothelin-1 and endothelial nitric oxide synthase in pulmonary arteries in rats with monocrotaline-induced pulmonary hypertension

✍ Takashi Takahashi; Tsugiyasu Kanda; Hiroyuki Sumino; Masahiro Inoue; Kunio Sato; 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 351 KB

Right-heart failure after right heart ca

Right-heart failure after right heart catheterization in a patient with scleroderma and suspected pulmonary hypertension

✍ Gernot Keyßer; Carola Schwerdt; Christiane Taege 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 250 KB